Exhibit 5.1
Wilson Sonsini Goodrich & Rosati Professional Corporation
650
Page Mill Road
o:
650.493.9300 |
March 31, 2023
RenovoRx, Inc.
4546 El Camino Real, Suite B1
Los Altos, CA 94022
Re: | Registration Statement on Form S-8 |
Ladies and Gentlemen:
We have examined the Registration Statement on Form S-8 (the “Registration Statement”) to be filed by RenovoRx, Inc., a Delaware corporation (the “Company”), with the Securities and Exchange Commission on or about the date hereof, relating to the registration under the Securities Act of 1933, as amended, of 272,931 shares of common stock, par value $0.0001 per share (the “Shares”), reserved for issuance pursuant to the Company’s 2021 Omnibus Equity Incentive Plan (the “2021 Plan”).
On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when issued and sold in the manner referred to in the 2021 Plan and pursuant to the agreements that accompany the 2021 Plan, will be validly issued, fully paid, and nonassessable.
We consent to the use of this opinion as an exhibit to the Registration Statement and further consent to the use of our name wherever appearing in the Registration Statement and any amendments thereto.
Very truly yours, | |
WILSON SONSINI GOODRICH & ROSATI | |
Professional Corporation | |
/s/ Wilson Sonsini Goodrich & Rosati, P.C. |
austin
beijing
boston
brussels
hong kong
london
los angeles
new york
palo alto
san diego
san francisco
seattle
shanghai
washington, dc
wilmington, de